Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
To demonstrate the safety and efficacy of adjunctive therapy with the Amikacin fosfomycin
inhalation system (AFIS) versus aerosolized placebo to treat Gram-negative pneumonia in
mechanically ventilated patients receiving IV antibiotics.